Devyser Diagnostics AB (publ) (DVYSR.ST)

SEK 117.0

(0.0%)

Total Assets Summary of Devyser Diagnostics AB (publ)

Devyser Diagnostics AB (publ)'s latest annual total assets in 2023 was 510.1 Million SEK , up 1.89% from previous year.
Devyser Diagnostics AB (publ)'s latest quarterly total assets in 2024 Q2 was 489.8 Million SEK , down -1.37% from previous quarter.
Devyser Diagnostics AB (publ) reported annual total assets of 500.63 Million SEK in 2022, up 9.58% from previous year.
Devyser Diagnostics AB (publ) reported annual total assets of 456.86 Million SEK in 2021, up 514.43% from previous year.
Devyser Diagnostics AB (publ) reported quarterly total assets of 489.8 Million SEK for 2024 Q2, down -1.37% from previous quarter.
Devyser Diagnostics AB (publ) reported quarterly total assets of 496.6 Million SEK for 2024 Q1, down -2.65% from previous quarter.

Annual Total Assets Chart of Devyser Diagnostics AB (publ) (2023 - 2018)

Historical Annual Total Assets of Devyser Diagnostics AB (publ) (2023 - 2018)

Year	Total Assets	Total Assets Growth
2023	510.1 Million SEK	1.89%
2022	500.63 Million SEK	9.58%
2021	456.86 Million SEK	514.43%
2020	74.35 Million SEK	0.89%
2019	73.7 Million SEK	52.84%
2018	48.22 Million SEK	0.0%

Year	Total Assets	Total Assets Growth
2024 Q3	462.9 Million SEK	-5.49%
2024 Q2	489.8 Million SEK	-1.37%
2024 Q1	496.6 Million SEK	-2.65%
2023 FY	510.1 Million SEK	1.89%
2023 Q4	510.1 Million SEK	-2.37%
2023 Q3	522.5 Million SEK	-0.87%
2023 Q2	527.1 Million SEK	8.28%
2023 Q1	486.8 Million SEK	-2.76%
2022 Q1	504.2 Million SEK	10.36%
2022 Q3	499.4 Million SEK	-1.15%
2022 Q2	505.2 Million SEK	0.2%
2022 Q4	500.63 Million SEK	0.25%
2021 Q4	456.86 Million SEK	0.0%

Peer Total Assets Comparison of Devyser Diagnostics AB (publ)

Name	Total Assets	Total Assets Difference
AroCell AB (publ)	174.89 Million SEK	-191.666%
Immunovia AB (publ)	98.68 Million SEK	-416.918%
Prostatype Genomics AB (publ)	49.22 Million SEK	-936.325%
SenzaGen AB	97.17 Million SEK	-424.924%
Spermosens AB	26.1 Million SEK	-1854.032%